Autopsy report · NCT04610489

Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19)

“Difficulty with recruiting for the study and with staffing the study.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 months before it stopped.
• 117 participants enrolled.
• Results were posted on the registry 5 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Carilion Clinic

Sponsor type

University, hospital or other

Conditions

Covid-19

Interventions

Quidel Sofia SARS Antigen FIA

Participants

117

Sites

1

Countries

United States

Trials that died the same way

• Normal Pressure Hydrocephalus Treatment by Acetazolamide
  “difficulty in recruiting participants to the study” (83% match in meaning)
• Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis
  “Not enough study participants, difficulties in recruitment” (80% match in meaning)
• Exercise Therapy for Asthma (ETA Trial)
  “Study proved difficult to recruit” (80% match in meaning)
• Tele-health Enabled Clinical Trial for COVID-19
  “Unable to overcome hurdles to study recruitment” (78% match in meaning)
• Effectiveness Ankle-7 Orthosis VS HAFO Orthosis on Gait in Diplegic CPChildren
  “Difficulties in recruiting” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.